Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Petri

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
The Lancet. Neurology|July 26, 2024
Targeting C9orf72 in people with ALSSusanne Petri
Lancet (London, England)|May 12, 2024
Acceptance and commitment therapy in improving quality of life in motor neuron diseaseSusanne Petri
The Lancet. Neurology|December 23, 2021
Major research advances in amyotrophic lateral sclerosis in 2021Susanne Petri
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 21, 2012
Changes in motor axon K(+) conductance in ALS. Primary or secondary to motor neuron degeneration?Reinhard Dengler, Susanne Petri
Journal of Neurology|August 29, 2024
Narrative review of diagnosis, management and treatment of dysphagia and sialorrhea in amyotrophic lateral sclerosisBogdan Bjelica, Susanne Petri
Current Opinion in Neurology|August 9, 2022
Progress in spinal muscular atrophy researchClaudia Wurster, Susanne Petri
Neurology|April 21, 2012
Hyperexcitability and amyotrophic lateral sclerosisMatthew C Kiernan, Susanne Petri
Neurology Research International|October 11, 2012
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALSSusanne Petri, Sonja Körner, Mahmoud Kiaei
Brain Sciences|April 3, 2021
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy PatientsAlma Osmanovic, Olivia Schreiber-Katz, Susanne Petri
Behavioural Brain Research|May 11, 2010
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS)Sarah Knippenberg, Nadine Thau, Reinhard Dengler, et al.
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
The Lancet. Neurology|July 26, 2024
Targeting C9orf72 in people with ALSSusanne Petri
Lancet (London, England)|May 12, 2024
Acceptance and commitment therapy in improving quality of life in motor neuron diseaseSusanne Petri
The Lancet. Neurology|December 23, 2021
Major research advances in amyotrophic lateral sclerosis in 2021Susanne Petri
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 21, 2012
Changes in motor axon K(+) conductance in ALS. Primary or secondary to motor neuron degeneration?Reinhard Dengler, Susanne Petri
Journal of Neurology|August 29, 2024
Narrative review of diagnosis, management and treatment of dysphagia and sialorrhea in amyotrophic lateral sclerosisBogdan Bjelica, Susanne Petri
Current Opinion in Neurology|August 9, 2022
Progress in spinal muscular atrophy researchClaudia Wurster, Susanne Petri
Neurology|April 21, 2012
Hyperexcitability and amyotrophic lateral sclerosisMatthew C Kiernan, Susanne Petri
Neurology Research International|October 11, 2012
Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALSSusanne Petri, Sonja Körner, Mahmoud Kiaei
Brain Sciences|April 3, 2021
Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy PatientsAlma Osmanovic, Olivia Schreiber-Katz, Susanne Petri
Behavioural Brain Research|May 11, 2010
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS)Sarah Knippenberg, Nadine Thau, Reinhard Dengler, et al.
Pageof 28